Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

If You Want to Go Far, Go Together: Lessons Learned from Quality Improvement Collaboratives in Palliative Care.

Journal of palliative medicine·2026

Same author

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice.

Clinical pharmacology in drug development·2026

Same author

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

CA: a cancer journal for clinicians·2025

Same author

Evaluation of Weight Gain and Overall Survival of Men Versus Women With Advanced Non-Small Cell Lung Cancer.

Journal of cachexia, sarcopenia and muscle·2025

Same author

CA turns 75: Looking at the future but never forgetting the roots.

CA: a cancer journal for clinicians·2025

Same author

Limited Sampling Strategy of Rosuvastatin Single-Time-point Concentrations Accurately Estimate Exposure and Constitutive Transporter Activities in Healthy Adults.

Therapeutic drug monitoring·2025

Same journal

The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection.

Journal of oncology practice·2019

Same journal

Oncologic Implications of Chronic Hepatitis C Virus Infection.

Journal of oncology practice·2019

Same journal

Considerations for Long-Term Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and Cancer.

Journal of oncology practice·2019

Same journal

Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.

Journal of oncology practice·2019

Same journal

Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences.

Journal of oncology practice·2019

Same journal

Management of Brain Metastases in Non-Small-Cell Lung Cancer.

Journal of oncology practice·2019

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Cancer Cachexia: Beyond Weight Loss.

Andrew R Bruggeman¹, Arif H Kamal¹, Thomas W LeBlanc¹

¹University of California at San Diego, San Diego, CA; Duke University Medical Center; and Duke University School of Medicine, Durham, NC; and University of Alberta, Edmonton, Alberta, Canada.

Journal of Oncology Practice

|November 19, 2016

Summary

This summary is machine-generated.

Cancer cachexia, marked by muscle loss, needs early identification beyond weight. Comprehensive management involves nutrition, exercise, and psychosocial support for better patient outcomes.

More Related Videos

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

Published on: May 31, 2016

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Mar 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

Published on: May 31, 2016

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

Area of Science:

Oncology
Metabolic Syndrome
Geriatrics

Background:

Cancer cachexia is a complex syndrome causing skeletal muscle loss and functional decline.
Current clinical practice faces challenges in preventing, identifying, and intervening in cachexia.
Existing definitions focusing solely on weight loss are insufficient for comprehensive management.

Purpose of the Study:

To highlight the challenges in defining and managing cancer cachexia.
To emphasize the need for early identification and multimodal interventions.
To guide oncologists in recognizing and addressing cachexia comprehensively.

Main Methods:

Review of current understanding and clinical challenges of cancer cachexia.
Analysis of limitations in existing diagnostic and treatment approaches.
Discussion of the multifactorial nature of cachexia and its management strategies.

Main Results:

Cancer cachexia significantly impacts quality of life, treatment toxicity, physical function, and mortality.
Current pharmacologic treatments may improve weight but not critical outcomes like muscle mass or survival.
Early identification requires assessment of body composition and physical functioning, not just weight loss.

Conclusions:

Recognizing cachexia beyond weight loss is crucial for practicing oncologists.
Effective cachexia management necessitates a multimodal approach including cancer therapy, symptom control, nutrition, exercise, and psychosocial support.
Referral to clinical trials is important for expanding treatment options for cachexia.